Similar articles for PMID: 20921206

Year	Number of Results
1979	1
1982	1
1987	1
1988	1
1991	1
1992	1
1993	3
1995	3
1996	3
1997	5
1998	2
1999	1
2000	1
2001	3
2002	3
2003	1
2004	3
2005	12
2006	9
2007	9
2008	17
2009	15
2010	18
2011	21
2012	33
2013	40
2014	17
2015	37
2016	26
2017	32
2018	25
2019	24
2020	19
2021	17
2022	25
2023	5
2024	0

1

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW. Duijvestein M, et al. Gut. 2010 Dec;59(12):1662-9. doi: 10.1136/gut.2010.215152. Epub 2010 Oct 4. Gut. 2010. PMID: 20921206 Clinical Trial.

2

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.

Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR. Ciccocioppo R, et al. Gut. 2011 Jun;60(6):788-98. doi: 10.1136/gut.2010.214841. Epub 2011 Jan 21. Gut. 2011. PMID: 21257987

3

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP. Forbes GM, et al. Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71. doi: 10.1016/j.cgh.2013.06.021. Epub 2013 Jul 19. Clin Gastroenterol Hepatol. 2014. PMID: 23872668 Clinical Trial.

4

Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.

Bernardo ME, Avanzini MA, Ciccocioppo R, Perotti C, Cometa AM, Moretta A, Marconi M, Valli M, Novara F, Bonetti F, Zuffardi O, Maccario R, Corazza GR, Locatelli F. Bernardo ME, et al. Cytotherapy. 2009;11(7):825-36. doi: 10.3109/14653240903121260. Cytotherapy. 2009. PMID: 19903096

5

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses.

Dhere T, Copland I, Garcia M, Chiang KY, Chinnadurai R, Prasad M, Galipeau J, Kugathasan S. Dhere T, et al. Aliment Pharmacol Ther. 2016 Sep;44(5):471-81. doi: 10.1111/apt.13717. Epub 2016 Jul 7. Aliment Pharmacol Ther. 2016. PMID: 27385373 Free article. Clinical Trial.

6

[Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases].

Lazebnik LB, Konopliannikov AG, Kniazev OV, Parfenov AI, Tsaregorodtseva TM, Ruchkina IN, Khomeriki SG, Rogozina VA, Konopliannikova OA. Lazebnik LB, et al. Ter Arkh. 2010;82(2):38-43. Ter Arkh. 2010. PMID: 20387674 Russian.

7

Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.

Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL. Cassinotti A, et al. Gut. 2008 Feb;57(2):211-7. doi: 10.1136/gut.2007.128694. Epub 2007 Sep 25. Gut. 2008. PMID: 17895357

8

Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.

Zhou H, Guo M, Bian C, Sun Z, Yang Z, Zeng Y, Ai H, Zhao RC. Zhou H, et al. Biol Blood Marrow Transplant. 2010 Mar;16(3):403-12. doi: 10.1016/j.bbmt.2009.11.006. Epub 2009 Nov 17. Biol Blood Marrow Transplant. 2010. PMID: 19925878 Free article. Clinical Trial.

9

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients.

Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, Mönckeberg G, Figueroa FE. Carrion F, et al. Lupus. 2010 Mar;19(3):317-22. doi: 10.1177/0961203309348983. Epub 2009 Nov 17. Lupus. 2010. PMID: 19919974

10

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A. Bocelli-Tyndall C, et al. Rheumatology (Oxford). 2007 Mar;46(3):403-8. doi: 10.1093/rheumatology/kel267. Epub 2006 Aug 18. Rheumatology (Oxford). 2007. PMID: 16920750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

392 results

Results by year